Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation

Scandinavian Journal of Immunology

Volumn 71, Issue 6, 2010, Pages 403-412

  Rask, C ^a   Brimnes, J ^a   Lund, K ^a  

^a ALK ABELLÓ   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHLEUM PRATENSE EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSAGE SCHEDULE COMPARISON; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFICACY; EOSINOPHIL; FEMALE; IMMUNOTHERAPY; LUNG LAVAGE; MOUSE; NONHUMAN; PHLEUM PRATENSE; PRIORITY JOURNAL; SKIN SENSITIZATION; TH2 CELL;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PHLEUM; RHINITIS, ALLERGIC, SEASONAL; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC;

EID: 77952276243     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02394.x     Document Type: Article

References (46)

1. Bousquet J, van CP, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 : S147 334.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004 24 : 758 764.
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998 102 : 558 562.
4. Durham SR, Ying S, Varney VA et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996 97 : 1356 1365.
5. Furin MJ, Norman PS, Creticos PS et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991 88 : 27 32.
6. Wilson DR, Irani AM, Walker SM et al. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001 31 : 1705 1713.
7. Brimnes J, Kildsgaard J, Jacobi H, Lund K. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin Exp Allergy 2007 37 : 488 497.
8. Neimert-Andersson T, Thunberg S, Swedin L et al. Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. Allergy 2008 63 : 518 526.
9. Razafindratsita A, Saint-Lu N, Mascarell L et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007 120 : 278 285.
10. Santeliz JV, Van NG, Traquina P, Larsen E, Wills-Karp M. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002 109 : 455 462.
11. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 2008 180 : 5211 5221.
12. Wiedermann U, Jahn-Schmid B, Lindblad M et al. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int Immunol 1999 11 : 1131 1138.
13. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007 120 : 707 713.
14. Francis JN, Till SJ, Durham SR. Induction of IL-10+ CD4+ CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 : 1255 1261.
15. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33 : 1205 1214.
16. O'Hehir RE, Sandrini A, Anderson GP, Rolland JM. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation. Curr Med Chem 2007 14 : 2235 2244.
17. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008 121 : 1467 1472. 1472.
18. Cooke R, Bernhard J, Hebald S, Stull A. Serological evidence of immunity with coexisting sensitization in hay fever type of human allergy. J Exp Med 1993 3 : 733 751.
19. Garcia BE, Sanz ML, Gato JJ, Fernandez J, Oehling A. IgG4 blocking effect on the release of antigen-specific histamine. J Investig Allergol Clin Immunol 1993 3 : 26 33.
20. Lichtenstein LM, Holtzman NA, Burnett LS. A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968 101 : 317 324.
21. Mothes N, Heinzkill M, Drachenberg KJ et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003 33 : 1198 1208.
22. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004 113 : 1025 1034.
23. Woodhead JS, Weeks I. Magic Lite design and development. J Biolumin Chemilumin 1989 4 : 611 614.
24. Bergquist C, Lagergard T, Lindblad M, Holmgren J. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect Immun 1995 63 : 2021 2025.
25. Kildsgaard J, Brimnes J, Jacobi H, Lund K. Sublingual immunotherapy in sensitized mice. Ann Allergy Asthma Immunol 2007 98 : 366 372.
26. Aberer W, Hawranek T, Reider N, Schuster C, Sturm G, Kranke B. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy. J Investig Allergol Clin Immunol 2007 17 : 131 136.
27. Dahl R, Kapp A, Colombo G et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008 121 : 512 518.
28. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 802 809.
29. Malling HJ, Lund L, Ipsen H, Poulsen L. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. J Investig Allergol Clin Immunol 2006 16 : 162 168.
30. Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004 114 : 831 837.
31. Ebner C, Siemann U, Bohle B et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997 27 : 1007 1015.
32. Fanta C, Bohle B, Hirt W et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999 120 : 218 224.
33. Jarolim E, Poulsen LK, Stadler BM et al. A long-term follow-up study of hyposensitization with immunoblotting. J Allergy Clin Immunol 1990 85 : 996 1004.
34. Marcucci F, Sensi L, Di CG, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy. Allergy 2005 60 : 952 956.
35. Savolainen J, Jacobsen L, Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006 61 : 1184 1190.
36. O'Hehir RE, Gardner LM, de Leon MP et al. House Dust Mite Sublingual Immunotherapy - The Role for TGF-beta and Functional Regulatory T Cells. Am J Respir Crit Care Med 2009 180 : 936 947.
37. Rask C, Fredriksson M, Lindblad M, Czerkinsky C, Holmgren J. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant. APMIS 2000 108 : 178 186.
38. Bahceciler NN, Arikan C, Taylor A et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 2005 136 : 287 294.
39. Francis JN, James LK, Paraskevopoulos G et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008 121 : 1120 1125.
40. Platts-Mills TA, von Maur RK, Ishizaka K, Norman PS, Lichtenstein LM. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest 1976 57 : 1041 1050.
41. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007 25 : 5467 5484.
42. Bottcher MF, Haggstrom P, Bjorksten B, Jenmalm MC. Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy 2002 32 : 1293 1298.
43. Payette K, Weiss NS. Salivary IgA levels in atopic children. Ann Allergy 1977 39 : 328 331.
44. van Asperen PP, Gleeson M, Kemp AS et al. The relationship between atopy and salivary IgA deficiency in infancy. Clin Exp Immunol 1985 62 : 753 757.
45. Mayer L. Review article: local and systemic regulation of mucosal immunity. Aliment Pharmacol Ther 1997 3 : 81 5.
46. Pilette C, Nouri-Aria KT, Jacobson MR et al. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol 2007 178 : 4658 4666.